Your solution

Bendamustine HCI

CAS Monohydrate: 1374784-02-7 CAS Anhydrous: 3543-75-7

Bendamustine HCI
Bendamustine hydrochloride is an alkylating antitumor agent indicated for the treatment of patients with:
  • Chronic lymphocytic leukaemia
  • Indolent B-cell non-Hodgkin’s lymphoma refractory to rituximab
  • Multiple myeloma, in combination with Prednisone
Bendamustine is on the World Health Organization model list of essential medicines.

Therapeutic group
Antineoplastic agents, alkylating agents
ATC code: L01AA09
Your selection
Bendamustine HCI

How can we support you with Bendamustine HCI?

I am looking for...